Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) until the end of March 2026
- This updates the news item of 9 October 2025
Neon Healthcare have advised NaTHNaC that 250mg mefloquine (Lariam) antimalarial tablets are currently out of stock in the UK and will not be available until the end of March 2026.
Advice for health professionals
Clinics and pharmacies with remaining supplies of mefloquine should prioritise travellers with imminent travel for whom mefloquine is the first choice of antimalarial. This includes pregnant travellers visiting high risk malaria regions such as Sub-Saharan Africa.
Travellers who can take alternative antimalarials should be prescribed these, in order to preserve mefloquine supplies for those who cannot use other options.
Country specific advice about malaria risks and antimalarial recommendations available from the TravelHealthPro Country Information pages.
The UK Malaria Expert Advisory Group (UKMEAG) Malaria prevention guidelines for travellers from the UK provide detailed malaria advice and guidance for health professionals advising travellers and are the first port of call for queries.
Alternative suppliers
The following specialist importers have confirmed they can source unlicensed mefloquine 250 mg tablets (please note there may be other companies that can also source supplies):
- Alium
- Chemys
- Genetech
- Smartway
- Target
Any decision to prescribe an unlicensed medicine must consider the relevant guidance and NHS Trust or local governance procedures. Unlicensed imports do not undergo any central quality assessment or suitability evaluation. Therefore, any import must be locally assessed in line with local unlicensed medicines processes. Please see the resources section below for further information.
If attempts to source mefloquine for an individual traveller are not successful, health professionals can contact NaTHNaC's telephone advice line for further advice.
The UK Health Security Agency Malaria Reference Laboratory offers an email advisory service for health professionals for complex queries which cannot be answered after consulting the Malaria prevention guidelines for travellers from the UK.
Resources
- Vaccines and medicines: availability, supply, shortages and use of unlicensed medicines – Information for health professionals on availability of vaccines and use of unlicensed products
- Medicines and Healthcare products Regulatory Agency (MHRA): The supply of unlicensed medicinal products
- Royal Pharmaceutical Society (RPS): Professional Guidance for the Procurement and Supply of Specials, Royal Pharmaceutical Society (RPS)
- General Medical Council (GMC): Prescribing unlicensed medicines, General Medical Council (GMC)
-
Shortage expected until the end of March 2026.
-
Alternative suppliers and additional references added.
Explore more
Global risk of measles: travel reminder
All travellers should check they are in date for measles (MMR or MMRV) vaccine
Updated: 27 January 2026Introducing the new Educational Events section on TravelHealthPro
New Events section is now live
Updated: 22 January 2026ABTA Destinations to Watch report published
ABTA has launched its Destinations to Watch report for 2026
Updated: 21 January 2026Travel during Ramadan
Traveling abroad during Ramadan is a rewarding experience, but can also present challenges; here are some tips for careful preparation to ensure a saf
Updated: 23 January 2026
